Caring for patients is now 99% information and 1% intervention.¹
QCI Interpret is clinical decision support software that reproducibly converts highly complex NGS data into clinician-ready reports, providing you with trusted information on variant pathogenicity, prognostic outcomes, and therapeutic actionability.
With QCI Interpret, you reliably get actionable insights in a concise, easy-to-read report for any indication, germline or somatic. Updated weekly via the QIAGEN Knowledge Base, QCI Interpret connects you to over 25 public and proprietary sources with full transparency to the underlying evidence.
When paired with QIAGEN’s Clinical Informatics Services, QCI Interpret can be customized with specific content, on-demand variant assessments, and standardized reporting workflows to fast-track testing.
• Rapid and comprehensive NGS variant interpretation using web-based software
Dr. Andreas Rump of the Institute for Clinical Genetics at Technical University Dresden shares how his lab tested the reliability and accuracy of QCI Interpret—QIAGEN’s web-based tertiary NGS interpretation platform.
• Case Study: Genetic testing lab sees 25-fold scale-up with QIAGEN Clinical Insight Interpret
This webinar offers a look at how an advanced genetics laboratory implemented and validated QIAGEN Clinical Insight Interpret to help scale operations and cut costs.
• Enabling genomics guided precision medicine with QCI Interpret
Do you need a clinical reporting solution that is highly accurate, reproducible and standardized? If you answered yes, we invite you to watch a free recording of our webinar that addresses one of the key bottlenecks of today’s clinical testing laboratory.
1 Chow, et al., Evidence-based medicine and precision medicine: Complementary approaches to clinical decision-making, Precision Clinical Medicine, 1(2): 2018.
Figure 1. White Paper: QIAGEN Knowledge Base and ClinVar: Avoiding the Knowledge Blind Spot
QIAGEN® Clinical Insight is an evidence-based decision support software intended as an aid in the interpretation of variants observed in genomic sequencing data. The software evaluates genomic variants in the context of published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels, and clinical-trials. Based on this evaluation, the software proposes a classification to aid in the interpretation of observed variants. The software is NOT intended as a primary diagnostic tool by physicians or to be used as a substitute for professional healthcare advice. Each laboratory is responsible for ensuring compliance with applicable international, national, and local clinical laboratory regulations and other specific accreditations requirements.